Skip to content

Frontiers in Psychiatry

ISSN 1664-0640

601 papers in the library · 9,228 citations · publishing 2010-2026

Papers

Sort Most recent Most cited

Evaluating a virtual reality–delivered mindfulness intervention for anxiety: a mixed-methods study in real-world community and school settings

Frontiers in Psychiatry December 11, 2025 Sima Rafiei, Kristof Santa, Nicola Honey et al. 3 citations

Introduction: , a six-session VR mindfulness programme designed for young people, delivered in real-world school and community environments. Methods: Using an exploratory pre-post mixed-methods design, data were collected from 53 participants across schools, community organisations, and youth mental health services. Recruitment was facilitator-led and internal to each site. Quantitative data...

Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysis

Frontiers in Psychiatry December 10, 2025 Terence H. W. Ching, B. Stahnke, Sarah Shnayder et al. 3 citations

Introduction The subjective effects of psilocybin on obsessive-compulsive disorder (OCD) are under-explored. Therefore, we conducted a qualitative study of participant experiences from the first randomized placebo-controlled trial of single-dose psilocybin combined with unstructured and non-directive support for individuals with treatment-refractory OCD. Our research explored how participants...

DOI: 10.3389/fpsyt.2025.1726818 (opens in new tab) Psilocybin Hallucinogen Interpretative phenomenological analysis Action physics +3

How do psychedelics impact people with a history of non-affective psychosis? A qualitative study.

Frontiers in Psychiatry December 9, 2025 Haley Maria Dourron, Heith Copes, Daniel H. Grossman et al. 3 citations

Background: People with a history of psychotic disorders are excluded from contemporary trials of psychedelic-assisted therapy. Although survey studies have explored the impact of naturalistic psychedelic use on people with a history of psychotic disorders, a qualitative study has yet to examine the subjective effects of psychedelic use in this population during both the acute effects and...

Commentary: Rethinking pathways to well-being: the function of faith practice in distress alleviation among displaced Muslim women affected by war

Frontiers in Psychiatry December 1, 2025 Aamer Aldbyani 3 citations

This article presents an expansive commentary on Rutledge's (2025) mixed-methods investigation into the role of faith practices in the psychological well-being of displaced Muslim women in northern Iraq. Rutledge's study makes an important contribution by demonstrating that religious devotion-particularly daily prayer, Qur'an recitation, and fasting-serves as a primary channel through which...

How digital mindfulness training promotes meaning in life among social workers: a parallel mediation analysis and latent profile analysis.

Frontiers in Psychiatry November 21, 2025 Chang Rui, Jun Cao, Fuqiang Tan

Introduction: This study investigates the mechanisms by which digital mindfulness training promotes meaning in life among social workers and explores individual heterogeneity in this process. Methods: A parallel mediation model was used to test the pathways from digital mindfulness training to meaning in life. Latent Profile Analysis (LPA) was employed to identify distinct subgroups among the...

DOI: 10.3389/fpsyt.2025.1700358 (opens in new tab) Full text (opens in new tab) Social workers Meaning in life Latent profile analysis Digital mindfulness training +1

Associations between psychedelic use and adverse outcomes in substance use disorders: a real-world EHR-based cohort study.

Frontiers in Psychiatry October 24, 2025 Fares Qeadan, Ashlie McCunn, Benjamin Tingey et al.

Aims: To examine associations between psychedelic use and adverse health outcomes, including overdose, relapse, mental health crises, and hospitalizations, among individuals with substance use disorders (SUD), and to compare these outcomes across different treatment modalities including anesthetics and outpatient SUD services. Design: Retrospective cohort study using propensity score-weighted...

Cracks in the pattern: Gallagher's theory of the self and the dynamics of schizophrenic selfhood.

Frontiers in Psychiatry October 3, 2025 István Fazakas, Thomas Fuchs, Samuel Thoma et al.

The contemporary debate on selfhood in philosophy, psychiatry, and cognitive science unfolds most often between two opposing tendencies: reductionism, seeking to identify a fundamental and minimal core of selfhood, and eliminativism, denying the existence of the self. Shaun Gallagher's Pattern Theory of the Self (PTS) has emerged as a promising alternative approach. By defining the self as a...

Recreational MDMA use in Norway: results from an internet convenience sample.

Frontiers in Psychiatry September 26, 2025 Cato Grønnerød, Thea Rønningen, Ingrid Rike Haugsjå et al.

The purpose of the article: In recent years, a renewed interest has emerged in investigating the use of MDMA in the treatment of mental disorders. However, knowledge about the characteristics of recreational use of MDMA, its contexts and effects are limited. Methods: We recruited adult Norwegian participants aged 18 to 65 who reported having had a memorable experience after using MDMA. They...

DOI: 10.3389/fpsyt.2025.1619676 (opens in new tab) Full text (opens in new tab) Ecstasy consumption Molly usage Recreational MDMA Use Drug taking +21

The concept of the schizophrenic lifeworld revisited.

Frontiers in Psychiatry September 26, 2025 Marco Kramer, Paraskevi Mavrogiorgou, Georg Juckel

Disturbances regarding the lifeworlds of patients with mental disorders are recurrently mentioned in psychiatric literature, but the concept often remains poorly defined and unclear. The present article takes the lifeworld in schizophrenia as an example to elucidate this concept. First, the concept "lifeworld" is traced back to its philosophical roots. The classical phenomenology particularly...

The role of meditation in coping with stress during the COVID-19 lockdown: a cross-sectional study of undergraduates in India.

Frontiers in Psychiatry September 24, 2025 Puja Munjal, Neetika Khurana, Manish Saggar et al.

Background: The COVID-19 pandemic significantly impacted mental health worldwide, particularly among college students. This study aimed to evaluate the effects of regular meditation practice on stress and well-being during the COVID-19 lockdown in college students from Delhi, India. Methods: Data were collected from April 22 to June 3, 2020. Participants included college students aged 18-26,...

A clinical protocol for group-based ketamine-assisted therapy in a community of practice: the Roots To Thrive model

Frontiers in Psychiatry September 22, 2025 Shannon Dames, Pamela Kryskow, Vivian W. L. Tsang et al. 3 citations

RTT-KaT offers a structured, scalable, evidence-informed, and culturally responsive model that bridges clinical safety with both Western and Indigenous knowledge systems. A longitudinal follow-up study is currently underway to evaluate long-term impact and guide future implementations.

DOI: 10.3389/fpsyt.2025.1568017 (opens in new tab) Protocol science Indigenous Medline Clinical trial +5

The collective lie in ketamine therapy: a call to realign clinical practice with neurobiology

Frontiers in Psychiatry September 22, 2025 Charles Miller, Bárbara Lopes, Anna Mccurdy

In recent years, ketamine therapy has become increasingly entangled with psychedelic culture, leading to widespread misinterpretation of its therapeutic mechanism. This manuscript challenges the prevailing narrative that positions ketamine as a consciousness-expanding agent or psychotherapy enhancer, highlighting the discord between this view and ketamine's well-established neurobiological...

DOI: 10.3389/fpsyt.2025.1610335 (opens in new tab) Ketamine Clinical practice Dissociative Narrative review +6

A biopsychosocial model of MDMA-assisted therapy in application: Dyadic One Session Treatment for specific phobia

Frontiers in Psychiatry September 5, 2025 Nicholas J. Ahari, Gregory A. Fonzo

3,4-methelenedioxymethamphetamine (MDMA) can be effective in treating posttraumatic stress disorder (PTSD) in controlled trials, potentially secondary to MDMA’s effects on neural circuits implicated in fear and reward. Although anxiety, stress, and fear-based disorders involve maladaptation of the neural circuits processing fear, threat, and reward, no studies have tested MDMA’s therapeutic...

Mindfulness, music, visual occlusion in ketamine therapy for depression: do they change outcomes? A qualitative and quantitative analysis of a randomized controlled trial

Frontiers in Psychiatry September 2, 2025 Mina Kheirkhah, Nastasia McDonald, Julia Aepfelbacher et al. 1 citation

Introduction: This is the first randomized controlled trial to use both qualitative and quantitative methods to evaluate the effects of a combined sensory intervention that included mindfulness, music, and a light-occluding eye mask during antidepressant-dose ketamine treatment for depression. Methods: Forty-three participants with unipolar depressive disorder enrolled in the study; 22...

DOI: 10.3389/fpsyt.2025.1642025 (opens in new tab) Mindfulness Ketamine Randomized controlled trial Music therapy +3

Psychedelic therapy: bridging neuroplasticity, phenomenology, and clinical outcomes.

Frontiers in Psychiatry September 1, 2025 Ronit Kishon, Yael M. Cycowicz

The resurgence of interest in psychedelic compounds as potential treatments for psychiatric disorders represents a paradigm shift in mental health care. Psychedelics exert their effects through serotonergic modulation, particularly via 5-HT2A receptor activation, inducing profound alterations in consciousness and catalyzing neuroplasticity. While their neurobiological effects are...

Prodromal dreams.

Frontiers in Psychiatry August 28, 2025 Patrick Mcnamara

I present a provisional model and promising evidence, pending robust longitudinal validation, for the possibility of prodromal dreams: dreams that predict onset of illness before overt symptoms appear. Interoceptive signals are compressed and summated/integrated within brain networks that are most highly active during REM sleep. If there is a bodily problem an error signal is generated and the...

Psychedelic minimalism: the case against music in psychedelic therapy settings.

Frontiers in Psychiatry August 26, 2025 Samir A Nader 3 citations

In recent years, renewed attention has been given to the centrality of set and setting inpsychedelic-assisted therapy. The Reporting of Setting in Psychedelic Clinical Trials (ReSPCT)guidelines reflect an evolving consensus: therapeutic outcomes are not solely pharmacologicallydetermined but are heavily shaped by both the environment and the psychological state of theparticipant...

Active inference and psychodynamics: a novel integration with applications to depression and stress disorders

Frontiers in Psychiatry August 19, 2025 Hebert W. Harris

This paper introduces Active Intersubjective Inference (AISI), a novel framework that integrates psychodynamic theory with predictive processing to explain self-identity construction and psychopathology. AISI posits that the self emerges from recursive inferences about how others perceive us (second-order self), interacting bidirectionally with interoceptive processes. We map psychodynamic...

DMT and harmala alkaloids: an exploratory study of oral Acacia based formulations in healthy volunteers.

Frontiers in Psychiatry August 15, 2025 Yvonne Bonomo, Amanda F. Norman, Lisa Collins et al. 1 citation

Introduction: Ayahuasca is a psychedelic compound of N, N, Dimethyltryptamine (DMT) and harmala alkaloids used for spiritual and medicinal applications in traditional settings. A range of potential psychotherapeutic mechanisms have been proposed for ayahuasca. These are thought to contribute to improvements in various psychiatric conditions including mood disorders and substance dependence....

DOI: 10.3389/fpsyt.2025.1545915 (opens in new tab) Full text (opens in new tab) Psychoactive Compounds DMT Harmala alkaloids Acacia Psychedelics +10

Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreat

Frontiers in Psychiatry August 6, 2025 Grace Blest‐hopley, Giuseppe Pasculli, Simon Ruffell et al. 3 citations

Introduction Psilocybin, a serotonergic psychedelic, has shown therapeutic potential in treating mental health disorders by, amongst the many effects, promoting neuroplasticity and reorganising functional connectivity across cortical and subcortical networks involved in emotion and cognition. Veterans with traumatic brain injuries (TBI) often experience chronic neurological and psychological...

Treatment-resistant depression and intranasal esketamine: Spanish consensus on theoretical aspects

Frontiers in Psychiatry August 4, 2025 Fernando Mora, J. Ramos-Quiroga, Enrique Baca-García et al. 5 citations

Introduction Depression is a highly prevalent disease that severely impacts the life of patients. Inadequate response to at least two antidepressants despite adequacy of treatment and adherence is known as treatment-resistant depression (TRD), which entails a higher social and economic burden than non-resistant major depression. The lack of consensus on the definition of TRD and other aspects...

Therapeutic and legal aspects of psilocybin in cancer-related depression

Frontiers in Psychiatry August 4, 2025 Wierzbicka Małgorzata, Renata Kopczyk, Alexander L. Gerlach et al. 1 citation

Depression prevalence is markedly elevated in oncological patients, particularly among head and neck cancer (HNC) cohorts, who face twice the prevalence of major depressive disorder (MDD) compared to other cancer populations. MDD in this context independently predicts poorer clinical outcomes and increased morbidity. HNC management often involves acute surgical interventions with disfiguring...

CB1 receptor and psychosis: friend, foe, or both

Frontiers in Psychiatry July 22, 2025 Jagadeesh Sridhara Rao, María Alejandra Tangarife, Diego A. Rodríguez‐Soacha et al.

Psychosis is a core issue in Schizophrenia (SZ), whereas in Alzheimer's disease (AD), the prevalence of psychosis, particularly hallucinations and delusions, is approximately 40 to 60% (1). The onset of psychosis varies in SZ and AD but shares similar structural, neurochemical changes, and genetic associations (2). Radiological and pathological studies reveal a common pattern of limbic system...